Diabetes Care in The Netherlands: - Novo Nordisk

More documents

Recommendations

Info

Medical treatments for Diabetes Type 1 and Type 2 can beeffective, however compliance is a huge challengeIt is possible to live a very good lifewith diabetes……But this requires compliance to a demandingtreatment scheme…Type 1 treatment:‘Living a pleasant life with diabetes is possible! But youneed to put an effort in it. Watch your blood levels,carbohydrate intake, treatment schedule; actuallyeverything you do. Every day again. That takes up energy,but is worthwhile. Because a healthy lifestyle makes youfeel good.’Type 2 treatment‘People with diabetes can eat everything that healthypeople enjoy, but the key to a safe diet is to limit intake ofunhealthy food’Stages ofprogressionActivitiesApplicabletoLifestyle Metformin SUD Insulin• Changinglifestyle;• Diet• Exercise• Intake ofpills 1 to 4times aday of met• Intake ofpills 1 to 4times aday of metand SUD• Injection of insulin 1to 4 times a day (withuse of pump Type 1)• Self measurement 3to 4 times a day• Adjusting insulinintake to lifestyle• Type 1 & 2 • Type 2 • Type 2 • Type 1 & 2Studies indicate non-compliance can be up to 65%Source:Beterlevenmetdiabetes.nl, diabetesfonds.nl, Booz && Company AnalysisBooz & Company 14 November 201150Prepared for Novo Nordisk43
Non-compliance leads to severe complications - - Diabetes affectsthe whole organismStroke(cerebrovascular disease)Heart disease(cardiovascular disease)Bacterial and fungalinfections of the skinSevere hardening ofthe arteries (atherosclerosis)SexualdysfunctionVisual impairment:diabetic retinopathy,cataract andglaucomaKidney disease(diabetic nephropathy)Autonomic neuropathy(including slow emptyingof the stomach and diarrhea)Poor blood supply to lower limbs(peripheral vascular disease)Necrobiosis lipidoicaGangreneSensory impairment(peripheral neuropathy)UlcerationSource: World Health Organization, American Diabetes Association, NIDDK, National Diabetes Statistics fact sheet. HHS, NIHBooz & Company 14 November 2011 Prepared for Novo Nordisk4451
Page 6 and 7: SummaryDiabetes is a serious and de
Page 8: diabetes care. Extra compensation w
Page 11 and 12: ContentsSummarized findings and rec
Page 13 and 14: 11Diabetes is a major and underesti
Page 15 and 16: 33Further improving health of of di
Page 17 and 18: 22Recommendation 2: Engage employer
Page 19 and 20: 44Recommendation 4: Introduce condi
Page 21 and 22: Already more than 1M diabetes patie
Page 23 and 24: Costs of of complications and treat
Page 25 and 26: Number of patients reaches ~1.4M in
Page 27 and 28: Increase in lost productivity is dr
Page 29 and 30: Diabetes care clearly improved in t
Page 31 and 32: Better compliance can be stimulated
Page 37 and 38: Delaying complications saves medica
Page 39 and 40: LimitedLimitedcollaborationcollabor
Page 41 and 42: Individual quality incentives are l
Page 43 and 44: Recommendation 1: Insurer should in
Page 47 and 48: Labour shortage from late nineties
Page 49 and 50: However, curative and participative
Page 51: ContentsSummarized findings and rec
Page 55: Facilitated patient networks are su
Page 58 and 59: Recommendation 3:Facilitate network
Page 62 and 63: But new medication could add a lot
Page 66: Booz & Company is a global manageme

Diabetes Care in The Netherlands: - Novo Nordisk

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?